Table 3 Antidiabetic property of ZnONP-α, ZnONP-β, ZnONP-γ, ZnONP-δ, ZnONP-ε and ZnO NP-η by inhibiting enzymes.

From: Biosynthesis of a range of ZnO nanoparticles utilising Salvia hispanica L. seed extract and evaluation of their bioactivity

Conc.

(µg/ml)

Acarbose (%)

Enzyme inhibition %

NPs-α

NP-β

NP-γ

NP-δ

NP-ε

NP-η

α-A

α-G

α-A

α-G

α-A

α-G

α-A

α-G

α-A

α-G

α-A

α-G

40

39.23

8.77

6.21

12.55

10.44

13.80

11.90

15.77

13.05

17.38

15.34

23.07

19.19

80

53.48

17.90

14.41

21.36

18.57

23.22

20.15

25.26

22.21

27.26

25.49

30.19

24.94

120

58.97

25.59

22.90

32.93

27.36

35.10

31.62

37.47

35.74

38.53

36.21

39.38

33.84

160

64.81

33.60

31.61

38.48

35.55

39.04

37.14

41.79

38.70

44.05

40.19

46.34

41.15

200

71.59

43.92

38.56

48.51

42.66

50.24

44.91

51.30

46.45

52.65

48.47

56.69

50.84

240

78.37

49.90

43.52

52.93

48.62

54.58

50.34

57.09

51.69

59.53

53.26

61.01

55.95

280

86.60

56.46

48.43

60.93

54.57

63.14

56.75

64.51

58.29

67.98

59.70

72.93

60.48

  1. All values in percent (%).
  2. α-A = α-amylase, α-G = α-glucosidase.
Back to article page